Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Salvalaggio

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 1, 2024
Correction to: Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in ItalyLuca Gentile, Anna Mazzeo, Chiara Briani, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 15, 2024
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in ItalyLuca Gentile, Anna Mazzeo, Chiara Briani, et al.
Journal of Neurology|August 19, 2021
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosisAlessandro Salvalaggio, Daniele Coraci, Laura Obici, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 6, 2023
Serum Neurofilament Light Chain in Replication Factor Complex Subunit 1 CANVAS and Disease SpectrumIlaria Quartesan, Elisa Vegezzi, Riccardo Currò, et al.
Brain : a Journal of Neurology|May 10, 2021
RFC1 expansions are a common cause of idiopathic sensory neuropathyRiccardo Currò, Alessandro Salvalaggio, Stefano Tozza, et al.
European Heart Journal|April 9, 2026
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impactFrancesco Cappelli, Carlo Fumagalli, Marco Luigetti, et al.
European Journal of Neurology|January 2, 2024
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variantsAlberto De Lorenzo, Giuseppe Liberatore, Pietro Emiliano Doneddu, et al.
Journal of Neurology|February 15, 2025
Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational studyVincenzo Di Stefano, Pietro Guaraldi, Angela Romano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 23, 2019
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotypeAndrea Cortese, Raffaella Lombardi, Chiara Briani, et al.
European Journal of Neurology|June 2, 2026
Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran-Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly)Marco Ceccanti, Pietro Guaraldi, Angela Romano, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 1, 2024
Correction to: Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in ItalyLuca Gentile, Anna Mazzeo, Chiara Briani, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 15, 2024
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in ItalyLuca Gentile, Anna Mazzeo, Chiara Briani, et al.
Journal of Neurology|August 19, 2021
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosisAlessandro Salvalaggio, Daniele Coraci, Laura Obici, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 6, 2023
Serum Neurofilament Light Chain in Replication Factor Complex Subunit 1 CANVAS and Disease SpectrumIlaria Quartesan, Elisa Vegezzi, Riccardo Currò, et al.
Brain : a Journal of Neurology|May 10, 2021
RFC1 expansions are a common cause of idiopathic sensory neuropathyRiccardo Currò, Alessandro Salvalaggio, Stefano Tozza, et al.
European Heart Journal|April 9, 2026
Cascade genetic screening in families with hereditary transthyretin amyloidosis: diagnostic and prognostic impactFrancesco Cappelli, Carlo Fumagalli, Marco Luigetti, et al.
European Journal of Neurology|January 2, 2024
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variantsAlberto De Lorenzo, Giuseppe Liberatore, Pietro Emiliano Doneddu, et al.
Journal of Neurology|February 15, 2025
Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational studyVincenzo Di Stefano, Pietro Guaraldi, Angela Romano, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 23, 2019
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotypeAndrea Cortese, Raffaella Lombardi, Chiara Briani, et al.
European Journal of Neurology|June 2, 2026
Deep Phenotyping of F64L Mutation in a Multicentric Cohort of Patisiran-Treated Hereditary Transthyretin Amyloidosis Patients (Patisiranitaly)Marco Ceccanti, Pietro Guaraldi, Angela Romano, et al.
Pageof 9